Collaboration: Page 2

Lumos Diagnostics extends deal to advance POC liver monitoring test to trials

By LabPulse.com staff writers

Lumos Diagnostics is expanding an existing deal with the Burnet Diagnostics Initiative that will advance a new point-of-care (POC) test for monitoring liver health in an upcoming clinical trial.

August 28, 2024

Scale Bio launches 100M cell challenge research initiative

By LabPulse.com staff writers

Scale Biosciences, in collaboration with Ultima Genomics and Nvidia, has launched a global initiative for single-cell research projects aimed at collectively analyzing 100 million cells or more across diverse biological systems and research areas.

August 19, 2024

EnPlusOne, Wyss Institute collaborate on disease-agnostic RNA therapeutic

By LabPulse.com staff writers

EnPlusOne Biosciences and the Wyss Institute are collaborating on a research initiative to develop a rapid, effectively deployable disease-agnostic RNA therapeutic.

August 16, 2024

Oxford Nanopore to collaborate on Singapore's national sequencing initiative

By LabPulse.com staff writers

Oxford Nanopore will participate in Singapore's National Precision Medicine program, which is aimed at developing a comprehensive genetic catalog of the country's population.

August 6, 2024

Roche, Ascidian to develop gene therapies for neurological diseases

By LabPulse.com staff writers

Roche has announced a research collaboration and licensing agreement with biotech firm Ascidian Therapeutics to develop gene therapies for neurological diseases.

June 19, 2024

ALZpath, Roche sign licensing agreement for dementia biomarker

By LabPulse.com staff writers

ALZpath has signed a licensing agreement with Roche for the use of the ALZpath pTau217 antibody to develop and commercialize a diagnostic blood test for Alzheimer's disease that will be offered on the Roche Elecsys platform.

June 12, 2024

Qiagen, Myriad Genetics to develop HRD test

By LabPulse.com staff writers

As part of their recently announced collaboration, Qiagen and Myriad Genetics will develop a kit-based test for analyzing homologous recombination deficiency (HRD) status.

June 5, 2024

Genialis, PanCAN partner to validate KRAS biomarker for pancreatic cancer

By LabPulse.com staff writers

Biomarker company Genialis and the Pancreatic Cancer Action Network (PanCAN) are collaborating to further the validation of the Genialis KrasID biomarker for pancreatic cancer using PanCAN's Know Your Tumor precision medicine service.

June 3, 2024

Danaher launches collaboration with Johns Hopkins University on TBI diagnostics

By LabPulse.com staff writers

Danaher has launched a partnership with Johns Hopkins University aimed at developing new traumatic brain injury (TBI) diagnostics.

May 9, 2024

Novo Nordisk Foundation, Wellcome, Gates Foundation to partner on global health challenges

By LabPulse.com staff writers

The Novo Nordisk Foundation, Wellcome, and the Bill & Melinda Gates Foundation have announced a collaboration to support scientific research and development for accessible solutions to global health challenges.

May 6, 2024

Astellas and Poseida to collaborate on oncology cell therapies

By LabPulse.com staff writers

Poseida Therapeutics and Astellas, under its Xyphos Biosciences subsidiary, have initiated a research collaboration and licensing agreement to develop allogeneic cell therapy programs by combining their innovative cell therapy platforms and technologies.

May 2, 2024

GSK, Genomics PLC collaborate on polygenic risk score use for clinical trials

By LabPulse.com staff writers

Genomics PLC and biopharmaceutical firm GSK have established a collaboration aimed at assessing the potential for using polygenic risk scores in clinical trials.

May 1, 2024

Previous Page

Page 2 of 8

Next Page